Major CRO taps 'big data' analytics to divine diabetes drug R&D success

Covance ($CVD), the large contract research organization (CRO), has formed an alliance with the 'big data' analytics outfit GNS Healthcare to work on computer models to aid predictions on the success of clinical trials and to zero in on patients likely to benefit from experimental drugs. fuels biotech's hunt for flu therapies

Crowdsourcing has empowered many different facets of biotech from funding startups to solving scientific riddles. might seem like an unlikely influence on this trend, yet drug researcher Sea Lane Biotechnologies tapped the major classifieds website to find samples for breaking flu research.

Ex-SAP boss bets $104M on cancer vaccine group

With part of his fortune made in the software business, Dietmar Hopp has taken a sizable interest in biotech. His investment group, dievini Hopp BioTech Holding, has committed $104 million to back Germany's CureVac as the biotech company readies for new trials of RNA vaccinations against prostate and non-small cell lung cancers.

Twitter starts to catch on in biotech

In the biotech arena, some people have become well-known by their Twitter handles that include the "@" symbol and some combination of numbers, letters and characters.

PerkinElmer grabs license to TIBCO Spotfire

PerkinElmer ($PKI) is raising its "Big Data" game and adding to its growing software offerings for biotech and pharma labs. The Waltham, MA-based company struck a deal with TIBCO Software to be the exclusive worldwide provider of TIBCO's analytics software Spotfire in certain scientific R&D markets.

China's BGI strikes deal to buy Complete Genomics for $117.6M

Complete Genomics' ($GNOM) search for strategic alternatives announced in June has led to a $117.6 million buyout deal with DNA sequencing competitor BGI. China-based BGI plans to scoop up Moutain View, CA-based Complete for $3.15 per share in cash as part of a move that would expand the company's U.S. footprint.

Boehringer Ingelheim debuts pharma game 'Syrum' on Facebook

After lots of pre-launch publicity, Boehringer Ingelheim has unveiled a beta version of its pharma game "Syrum" on Facebook. It's an evolution in the pharmaceutical industry's use of the social media platform and gives the German drugmaker a new tool to educate the general public about the challenges of its business.

Pfizer taps cloud computing to gain control of supply chain

Pfizer ($PFE) has treated the complications of its supply chain with doses of cloud computing, virtualization and other tools, enabling the drug giant to track shipments from a large network of internal and external sources with improved efficiency and accuracy, The Financial Times reports.

Illumina partners with Partners HealthCare to combine sequencing and software

The San Diego-based genomics company and Partners HealthCare in Boston have agreed to combine technologies, supporting the use of the hospital system's GeneInsight software to interpret sequencing data from Illumina's MiSeq system in a seamless fashion.

Annovation finds $8M for virtual biotech plan

The do-more-with-less mentality is alive and well in biotech. Atlas Venture Development Corp., a unit of the VC firm Atlas Venture, has shown again that a skeleton crew of full-time staff can run a drug development program on a tight budget with the help of outside contracts.

Aris Global plans 50 hires for pharma software outpost in Ireland

Pharma software provider Aris Global aims to hire 50 workers for a planned office in Dublin with support from the Irish government.

Pharma flocks to social media analytics

Pharma groups lack clarity on authorized marketing activities on social media websites, but that hasn't kept certain drugmakers from seeking ways to analyze the information generated on platforms such as Facebook and Twitter.

Pinterest attracts more pharma outfits

Pinterest trails social media heavyweights such as Facebook and Twitter in popularity among life sciences companies, but the fast-growing photo-sharing social website presents pharma outfits with another platform for reaching millions of people online.

ENCODE generates 15 trillion bytes of data for researchers

The ENCODE project--the initial results of which were released last week--was in some ways a computational biology phenomenon. It found that 80% of human DNA is active and necessary and will pay benefits to drug researchers for decades to come.

Informatics research may kill old-school databases

A move by the National Library of Medicine to fund informatics research is threatening the continuation of popular online databases where drug scientists can access vast stores of data specific to their research.

Merck Serono bioinformatics head starts new company

Jérôme Wojcik, former director of bioinformatics at Merck Serono, is starting a new company, Quartz Bio, to do biomarker data management and exploratory biomarker analysis services that will be supported under Merck Serono's Entrepreneur Partnership Program, reports PharmaTimes.

CLC bio buys molecular docking software company Molegro

Danish bioinformatics outfit, CLC bio has added Molegro, a drug discovery and data-mining software maker, to its portfolio of products.

Video game players take on deadly sepsis for U.S. military

A unit of the U.S. Department of Defense has challenged the Foldit video gamers to craft proteins in a virtual online setting that bind to pathogens in the blood, to bolster research of sepsis treatments.

CLC bio adds bioinformatics to $10M program

Danish bioinformatics outfit CLC bio has grabbed a $2 million share of a $10 million EU-funded grant program to developed systems to identify pathogens from clinical samples.

PerkinElmer partners with MGH on informatics system for cancer research

The new system is based on the informatics platform PerkinElmer picked up through its acquisition last year of Geospiza, one of several software companies PerkinElmer bought to beef up its technology offerings to life sciences outfits. At MGH, the new system is expected to aid investigators working on new cancer treatments.